Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H(HK:2315)
HK$39.98-1.42 (-3.43%)
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H ownership
HK$39.98
At close:-1.42 (-3.43%)
Want to see HK:2315 full AI Analyst Report?
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Ownership - Who Owns Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H?
1 Followers
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Ownership Overview
- 0.14% Mutual Funds
- 0.42% ETFs
- 99.44% Public Companies and Individual Investors
The ownership structure of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) stock is a mix of institutional, retail, and individual investors. Approximately 0.56% of the company’s stock is owned by Institutional Investors, and 99.44% is owned by Public Companies and Individual Investors.
The ownership structure of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) stock is a mix of institutional, retail, and individual investors. Approximately 0.56% of the company’s stock is owned by Institutional Investors, and 99.44% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| First Trust | 394,000 | Institution | 0.36% | 2,079,138 |
| Dfa Investment Dimensions Group Inc | 98,000 | Institution | 0.09% | 517,146 |
| Fidelity Rutland Square Trust Ii | 29,093 | Institution | 0.03% | 153,524 |
| Amundi | 27,792 | Institution | 0.03% | 146,658 |
| Goldman Sachs Trust | 23,000 | Institution | 0.02% | 121,371 |
| Avantis | 18,500 | Institution | 0.02% | 97,625 |
| Dimensional | 8,500 | Institution | <0.01% | 44,855 |
| Catholic Responsible Investments Funds | 6,500 | Institution | <0.01% | 34,301 |
| State Street | 5,500 | Institution | <0.01% | 29,024 |
| Jpmorgan | 3,500 | Institution | <0.01% | 18,470 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Dfa Investment Dimensions Group Inc | 98,000 | Institution | 0.09% | 517,146 |
| Fidelity Rutland Square Trust Ii | 29,093 | Institution | 0.03% | 153,524 |
| Goldman Sachs Trust | 23,000 | Institution | 0.02% | 121,371 |
| Catholic Responsible Investments Funds | 6,500 | Institution | <0.01% | 34,301 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| First Trust Emerging Markets AlphaDEX Fund, FEM ETF | 394,000 | Institution | 0.36% | 2,078,997 |
| Avantis Emerging Markets Equity ETF, AVEM ETF | 17,000 | Institution | 0.02% | 94,730 |
| Amundi Prime Europe UCITS ETF, GB:PRAM ETF | 12,000 | Institution | 0.01% | 65,896 |
| Dimensional Emerging Core Equity Market ETF, DFAE ETF | 8,500 | Institution | <0.01% | 47,481 |
| SPDR S&P China ETF, GXC ETF | 5,500 | Institution | <0.01% | 30,723 |
| Amundi Prime All Country World UCITS ETF Accum- USD, IT:WEBN ETF | 5,264 | Institution | <0.01% | 27,993 |
| Amundi Prime All Country World UCITS ETF USD, GB:PACW ETF | 5,264 | Institution | <0.01% | 27,993 |
| Amundi Prime All Country World UCITS ETF Hedged GBP, GB:WEHG ETF | 5,264 | Institution | <0.01% | 27,993 |
| JPMorgan BetaBuilders Emerging Markets Equity ETF, BBEM ETF | 3,500 | Institution | <0.01% | 19,503 |
| Goldman Sachs MarketBeta Total International Equity ETF, GXUS ETF | 2,000 | Institution | <0.01% | 10,555 |
FAQ
What percentage of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.56% of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) stock is held by institutional investors: 0.14% by mutual funds and 0.42% by ETFs.
What percentage of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.44% of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) stock is held by public companies and individual investors.
Who owns the most shares of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)?
First Trust owns the most shares of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

